Michael Kagnoff, Director at GenMark Diagnostics, Inc. (GNMK), bought 2,500 shares at $4.90 ($12K) on 2016-03-10, disclosed to the SEC on 2016-03-14.
Open-market purchase of $12k GNMK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| GNMK | BUY | 2017-11-06 | $83K | — | Filing → |
| GNMK | BUY | 2017-09-11 | $23K | — | Filing → |
| GNMK | BUY | 2016-11-22 | $24K | — | Filing → |